Company: SHPH
Filing Date: 2025-03-31
Form Type: DEF 14A
Source: 0001641172-25-001889
Chunk: 13

Company: Shuttle Pharmaceuticals Holdings, Inc.
Filing Date: 2025-03-31
Form: DEF 14A
Chunk 13
---
,                                          
 or until such director’s earlier resignation or removal.                                                                           
 We                                                                                                                                 
 believe that each of the nominees brings a set of experience and qualifications that positions our Board of Directors well to lead 
 the Company in the best interest of stockholders.                                                                                  
 The                                                                                                                                
 Board of Directors therefore recommends you vote “FOR” each of the nominees set forth below.                                       |

Nominees

| 1. | Anatoly            
 Dritschilo, M.D.   |
| 2. | Steve              
 Richards, MBA, CPA |
| 3. | George             
 Scorsis            |
| 4. | Oleh               
 Nabyt              |
| 5. | Joseph             
 Tung               |

Vote Required

A majority of the shares present in person or by proxy and entitled to vote at our 2025 Annual Meeting is required to approve Proposal No. 1.

| 11 |

Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm

ForvisMazars, LLP served as the Company’s independent registered public accounting firm since March 21, 2023 and has audited the Company’s financial statements as incorporated in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024.

Fees Paid to the Independent Public Accounting Firm

The following table represents fees for professional audit services for the audit of the Company’s annual financial statements for the fiscal years ended December 31, 2024 and December 31, 2023 rendered by Forvis Mazars, LLP.

|                  |     | Fiscal                  
 year ended December 31, |    2024 |     |   |    2023 |
|:-----------------|:----|:------------------------|--------:|:----|:--|--------:|
| Audit Fees 1     |     | $                       | 676,081 |     | $ | 429,555 |
| Other Audit Fees |     |                         |       - |     | $ |       - |
| Tax Fees 2       |     | $                       |       - |     | $ |       - |
| Total fees       |     | $                       | 676,081 |     | $ | 429,555 |

| 1. | Audit                                                                                                                                  
 fees consist of fees for professional services rendered by the principal accountant for the audit of the Company’s annual financial    
 statements included in the Company’s Form 10-K and review of the financial statements included in the Company